LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

Smith & Nephew PLC ADR

Geschlossen

36.61 0.97

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

36.35

Max

36.76

Schlüsselkennzahlen

By Trading Economics

Einkommen

296M

Verkäufe

3B

KGV

Branchendurchschnitt

32.604

108.767

Dividendenrendite

2.11

Gewinnspanne

9.895

Angestellte

17,000

EBITDA

723M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-5.04% downside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.11%

2.21%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

15B

Vorheriger Eröffnungskurs

35.64

Vorheriger Schlusskurs

36.61

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Smith & Nephew PLC ADR Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

25. Feb. 2026, 23:25 UTC

Heiße Aktien

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25. Feb. 2026, 23:15 UTC

Ergebnisse

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25. Feb. 2026, 23:54 UTC

Market Talk

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25. Feb. 2026, 23:47 UTC

Ergebnisse

Ferrovial 4Q Net EUR197M >FER.MC

25. Feb. 2026, 23:45 UTC

Ergebnisse

Ferrovial 4Q Rev EUR2.72B >FER.MC

25. Feb. 2026, 23:42 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25. Feb. 2026, 23:38 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Company's Business Operations Remain Normal >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25. Feb. 2026, 23:25 UTC

Ergebnisse

Trip.com FY EPS CNY47.67 >TCOM

25. Feb. 2026, 23:06 UTC

Ergebnisse

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25. Feb. 2026, 23:01 UTC

Ergebnisse

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25. Feb. 2026, 23:00 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

25. Feb. 2026, 23:00 UTC

Market Talk
Ergebnisse

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25. Feb. 2026, 22:56 UTC

Market Talk
Ergebnisse

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25. Feb. 2026, 22:43 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25. Feb. 2026, 22:40 UTC

Market Talk
Ergebnisse

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25. Feb. 2026, 22:40 UTC

Ergebnisse

Karoon Energy Says Search for New CFO Well Advanced

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says CFO Ray Church to Leave Company

25. Feb. 2026, 22:39 UTC

Ergebnisse

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25. Feb. 2026, 22:38 UTC

Ergebnisse

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer-Vergleich

Kursveränderung

Smith & Nephew PLC ADR Prognose

Kursziel

By TipRanks

-5.04% Nachteil

12-Monats-Prognose

Durchschnitt 34.46 USD  -5.04%

Hoch 34.91 USD

Tief 34 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Smith & Nephew PLC ADR – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

2 ratings

0

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

26.64 / 28.37Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat